Roche gets positive CHMP opinion for Tecentriq plus Avastin to treat liver cancer
The recommendation from the CHMP is based on results from the Phase III IMbrave150 study, which showed that Tecentriq in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
liver cancer
US FDA declines to approve Merck and Eisai’s liver cancer combo therapy
The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a…